Search Results Search Sort by RelevanceMost Recent In the Literature Apr 2005 Self-Regulation and the Relationship of Physicians with the Pharmaceutical Industry Justin M. Thomas Virtual Mentor. 2005;7(4):288-293. doi: 10.1001/virtualmentor.2005.7.4.jdsc1-0504. Policy Forum Feb 2005 The Oregon Plan and QALYs Fritz Allhoff Virtual Mentor. 2005;7(2):187-190. doi: 10.1001/virtualmentor.2005.7.2.pfor2-0502. Policy Forum Feb 2005 Some Ethical Corrections to Valuing Health Programs in Terms of Quality-Adjusted Life Years (QALYs) Erik Nord, PhD Virtual Mentor. 2005;7(2):191-194. doi: 10.1001/virtualmentor.2005.7.2.pfor3-0502. Policy Forum Feb 2005 Quality of Life as the Basis of Health Care Resource Allocation: A Philosopher's Perspective on QALYs Richard E. Ashcroft, PhD Virtual Mentor. 2005;7(2):195-199. doi: 10.1001/virtualmentor.2005.7.2.pfor4-0502. State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504. Medicine and Society Feb 2005 Medicine Goes to the Mall: Enhancement Technologies and Quality of Life Carl Elliott, MD, PhD Virtual Mentor. 2005;7(2):200-202. doi: 10.1001/virtualmentor.2005.7.2.msoc1-0502. Case and Commentary Jun 2006 Hidden Costs of Free Samples Richard Adair, MD Virtual Mentor. 2006;8(6):367-371. doi: 10.1001/virtualmentor.2006.8.6.ccas2-0606. Case and Commentary Jun 2006 The Gift-Giving Influence Frederick S. Sierles, MD Virtual Mentor. 2006;8(6):372-376. doi: 10.1001/virtualmentor.2006.8.6.ccas3-0606. Case and Commentary Mar 2006 To Scan or Not To Scan? Marion Danis, MD Virtual Mentor. 2006;8(3):135-137. doi: 10.1001/virtualmentor.2006.8.3.ccas2-0603. Case and Commentary Mar 2006 The Pitfalls of Drug Company Sample Use Robert Goodman, MD Virtual Mentor. 2006;8(3):138-141. doi: 10.1001/virtualmentor.2006.8.3.ccas3-0603. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
In the Literature Apr 2005 Self-Regulation and the Relationship of Physicians with the Pharmaceutical Industry Justin M. Thomas Virtual Mentor. 2005;7(4):288-293. doi: 10.1001/virtualmentor.2005.7.4.jdsc1-0504.
Policy Forum Feb 2005 The Oregon Plan and QALYs Fritz Allhoff Virtual Mentor. 2005;7(2):187-190. doi: 10.1001/virtualmentor.2005.7.2.pfor2-0502.
Policy Forum Feb 2005 Some Ethical Corrections to Valuing Health Programs in Terms of Quality-Adjusted Life Years (QALYs) Erik Nord, PhD Virtual Mentor. 2005;7(2):191-194. doi: 10.1001/virtualmentor.2005.7.2.pfor3-0502.
Policy Forum Feb 2005 Quality of Life as the Basis of Health Care Resource Allocation: A Philosopher's Perspective on QALYs Richard E. Ashcroft, PhD Virtual Mentor. 2005;7(2):195-199. doi: 10.1001/virtualmentor.2005.7.2.pfor4-0502.
State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504.
Medicine and Society Feb 2005 Medicine Goes to the Mall: Enhancement Technologies and Quality of Life Carl Elliott, MD, PhD Virtual Mentor. 2005;7(2):200-202. doi: 10.1001/virtualmentor.2005.7.2.msoc1-0502.
Case and Commentary Jun 2006 Hidden Costs of Free Samples Richard Adair, MD Virtual Mentor. 2006;8(6):367-371. doi: 10.1001/virtualmentor.2006.8.6.ccas2-0606.
Case and Commentary Jun 2006 The Gift-Giving Influence Frederick S. Sierles, MD Virtual Mentor. 2006;8(6):372-376. doi: 10.1001/virtualmentor.2006.8.6.ccas3-0606.
Case and Commentary Mar 2006 To Scan or Not To Scan? Marion Danis, MD Virtual Mentor. 2006;8(3):135-137. doi: 10.1001/virtualmentor.2006.8.3.ccas2-0603.
Case and Commentary Mar 2006 The Pitfalls of Drug Company Sample Use Robert Goodman, MD Virtual Mentor. 2006;8(3):138-141. doi: 10.1001/virtualmentor.2006.8.3.ccas3-0603.